LIANTONIO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 5.254
EU - Europa 1.069
AS - Asia 570
SA - Sud America 6
OC - Oceania 4
AF - Africa 3
Totale 6.906
Nazione #
US - Stati Uniti d'America 5.248
CN - Cina 404
SE - Svezia 281
IT - Italia 238
UA - Ucraina 155
DE - Germania 110
FI - Finlandia 104
SG - Singapore 99
GB - Regno Unito 72
FR - Francia 40
BE - Belgio 31
VN - Vietnam 27
IN - India 20
CZ - Repubblica Ceca 15
IE - Irlanda 10
IR - Iran 10
CA - Canada 6
NL - Olanda 5
CL - Cile 4
JP - Giappone 4
AU - Australia 3
HK - Hong Kong 3
BR - Brasile 2
CH - Svizzera 2
MA - Marocco 2
RU - Federazione Russa 2
BD - Bangladesh 1
DK - Danimarca 1
EE - Estonia 1
KE - Kenya 1
LT - Lituania 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TR - Turchia 1
Totale 6.906
Città #
Fairfield 738
Woodbridge 566
Chandler 439
Houston 386
Jacksonville 377
Ashburn 355
Cambridge 316
Seattle 285
Nyköping 247
Wilmington 241
Ann Arbor 232
Lawrence 104
Roxbury 103
Bari 102
Nanjing 87
Princeton 82
Singapore 82
Des Moines 65
New York 61
Inglewood 60
Beijing 55
Boardman 49
Jiaxing 36
San Diego 36
Los Angeles 33
Nanchang 32
Brussels 31
Dong Ket 27
Hebei 27
Shenyang 27
Falls Church 20
Milan 19
Santa Clara 18
Dearborn 16
Brno 15
London 15
Changsha 14
Helsinki 13
Paris 13
Shanghai 13
Guangzhou 12
Pune 12
San Mateo 12
Dublin 10
Tianjin 10
Zhengzhou 10
Genova 9
Hefei 9
Monmouth Junction 9
Redwood City 9
Taranto 9
Ardabil 8
Augusta 8
Brooklyn 7
Leawood 7
Kunming 6
Washington 6
Indiana 5
Jinan 5
Ningbo 5
Norwalk 5
Prescot 5
Toronto 5
Wuhan 5
Campobello Di Mazara 4
Genoa 4
Grafing 4
Marseille 4
San Francisco 4
Trani 4
Wuxi 4
Fuzhou 3
Kilburn 3
Santa Marinella 3
Sennori 3
Acton 2
Altamura 2
Bollate 2
Cisano Bergamasco 2
Grottaglie 2
Haikou 2
Hong Kong 2
Hounslow 2
Ksar el Kbir 2
Martina Franca 2
Mumbai 2
Naples 2
New Bedfont 2
Nulvi 2
Santiago 2
São Paulo 2
Tokyo 2
Torino 2
Trieste 2
Vinovo 2
Zurich 2
Apricena 1
Aradeo 1
Arzano 1
Auckland 1
Totale 5.711
Nome #
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force 142
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 139
Effects of Nandrolone in the counteraction of skeletal muscle atrophy in a mouse model of muscle disuse: molecular biology and functional evaluation 138
Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin 124
Ion channels in drug discovery and safety pharmacology 124
Antioxidant treatment of hindlimb-unloaded mouse counteracts fiber type transition but not atrophy of disused muscles 119
Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options 114
On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles 113
Activation and inhibition of kidney CLC-K chloride channels by fenamates 112
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 112
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 108
Carboxylic acids and skeletal muscle chloride channel conductance: Effects on the biological activity induced by the introduction of an aryloxyalkyl group α to the carboxylic function of 4-chloro-phenoxyacetic acid 99
null 99
Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1 98
Recovery of the soleus muscle after short- and long-term disuse induced by hindlimb unloading: effects on the electrical properties and myosin heavy chain profile 96
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives 94
Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness 93
null 92
Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan 92
Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse 91
null 90
Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine 90
Fiber type-related changes in rat skeletal muscle calcium homeostasis during aging and restoration by growth hormone 89
Taurine and skeletal muscle ion channels 88
The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo 88
null 86
Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels 85
Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels 84
Paracrine Effects of IGF-1 Overexpression on the Functional Decline Due to Skeletal Muscle Disuse: Molecular and Functional Evaluation in Hindlimb Unloaded MLC/mIgf-1 Transgenic Mice 83
Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium 82
Molecular determinants of differential pore blocking of kidney CLC-K chloride channels 78
A multidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic mdx mice 78
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery 76
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 76
New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse 75
Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1 74
Involvement of Barttin Subunit in Pharmacological Potentiation of CLC-K Channels Expressed in Xenopus Oocytes 73
Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle 73
Taurine and skeletal muscle disorders 72
Paving the way for Bartter syndrome type 3 drug discovery: a hope from basic research 72
Pharmacology of CLC chloride channels and transporters 70
Peptidic and Nonpeptidic Growth Hormone Secretagogues exert a protective effect on mitochondrial parameters analysed in a rat model of cachexia 69
null 69
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 69
null 68
Effect of HMG-CoA reductase inhibitors on excitation-contraction coupling of rat skeletal muscle 66
Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers 65
Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes 65
Protein Kinase C-Theta Controls the CLC-1 Chloride Channel Function and Skeletal Muscle Phenotype: A Biophysical and Gene Expression Study in Pkc-Theta Null Mice 64
Potential targets for skeletal muscle impairment by hypogravity: basic characterization of resting ionic conductances and mechanical threshold of rat fast- and slow-twitch muscle fibers 64
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by different impairing ClC-1 channel regulation and expression 64
Molecular switch for CLC-K Cl– channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands 63
Investigating a Benzofurane Derivative Binding Site on Human CLC-5 62
Effect of rat hindlimb suspension on cable properties, ionic conductances and fiber type composition of slow-twitch muscle. 62
I-J loop involvement in the pharmacological profile of CLC-K channels expressed in Xenopus oocytes 62
Therapeutic approaches to ion channel diseases 61
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/non-peptidyl structure 61
Comparison of excitability parameters and sodium channel behavior of fast- and slow-twitch rat skeletal muscles for the study of the effects of hindlimb suspension, a model of hypogravity. 59
Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductance 59
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies 59
Functional Study of Novel Bartter's Syndrome Mutations in ClC-Kb and Rescue by the Accessory Subunit Barttin Toward Personalized Medicine 58
Molecular determinants of 2(p-chlorophenoxy)propionic acid for modulation of the native chloride channel conductance of rat skeletal muscle 56
Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle 56
Taurine and skeletal muscle ion channels 56
Calcium homeostasis is altered in skeletal muscle of spontaneously hypertensive rats cytofluorimetric and gene expression analysis 55
Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat 54
Mechanism of Interaction of Niflumic Acid with Heterologously Expressed Kidney CLC-K Chloride Channels 54
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid 54
Mechanism of block of single protopores of the Torpedo chloride channel ClC-0 by 2-(p-chlorophenoxy)butyric acid (CPB) 53
Antioxidant treatment of hindlimb-unloaded mouse in vivo counteracts fiber type transition but not atrophy of disused skeletal muscles 52
Block of renal CLC-K channels by phenoxy-alkyl derivatives of clofibric acid 52
Kv1.1 channelopathies: Pathophysiological mechanisms and therapeutic approaches 51
null 49
Potent effect of chiral derivative of mexiletine on rat skeletal muscle sodium channel 48
Age-dependent effects of disuse on electrophysiogical parameters and calcium homeostasis in the soleus muscle of hindlimb-unloaded mice 47
Potent and stereoselective use-dependent block of skeletal muscle Na+ channels by a new proline-like tocainide derivative 45
null 45
Protein kinase C theta (PKCθ) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: a biophysical and gene expression study in mouse models lacking the PKCθ 44
Mechanisms of block of muscle type CLC chloride channels 43
Farmaci per il trattamento delle malattie muscolari 43
In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: A new drug target for hypertension? 43
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 43
Niflumic acid derivatives modulate macroscopic chloride conductance of native rat skeletal muscle by inhibiting the CLC-1 channel and by increasing the intracellular calcium level 41
Alteration of stim1/orai1-mediated soce in skeletal muscle: Impact in genetic muscle diseases and beyond 41
Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach 40
Taurine ameliorates in vitro and in vivo the electrical and contractile properties of skeletal muscle fibres of dystrophic mdx mouse 39
Pharmacology of chloride channels belonging to the CLC family 36
On the mechanism of the interaction of niflumic acid with kidney CLC-K chloride channels 36
Investigation of human CLC-K kidney channel block by extracellular ligands 36
An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 35
Inflammatory pathways and dystrophic progression: effect of in vivo treatment with either target-specific or wide-acting drugs on functional, biochemical and histological markers of muscle damage in exercised mdx mice 34
Independent impairment of chloride channel function and calcium homeostasis in dystrophic muscle of exercised MDX mouse 33
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders 32
Skeletal muscle impairment during microgravity-induced disuse: Beneficial effects of different pharmacological countermeasures 31
Growth hormone secretagogues modulate the electrical an contractile properties of rat skeletal muscle through a ghrelin-specific receptor 29
Evaluation of drug efficacy on muscular dystrophy by in vivo treatments in exercised mdx mouse 28
Simulated microgravity modifies the activity of protein kinase C and serine-threonine phosphatase controlling the resting chloride channel conductance in skeletal muscle 26
Renal CLC-K chloride channels heterologously coexpressed with barttin are specifically affected by 2-(p-chlorophenoxy)propionic acid derivatives 25
Effetti sulla conduttanza dei canali al cloro della muscolatura scheletrica indotti dall’introduzione di un sostituente arilossialchilico in a alla funzione carbossilica dell’acido 4-cloro-fenossiacetico 24
Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity 24
Totale 6.783
Categoria #
all - tutte 31.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.324 0 0 43 157 177 111 197 147 218 83 144 47
2020/20211.196 140 61 80 99 107 35 92 65 113 193 133 78
2021/2022867 42 143 10 32 42 63 48 37 56 57 131 206
2022/20231.252 200 113 93 91 125 186 13 147 192 17 36 39
2023/2024494 31 79 26 64 50 106 24 20 5 36 7 46
2024/2025251 81 37 133 0 0 0 0 0 0 0 0 0
Totale 7.187